Operating income increased 34.0%
Operating income changed +34.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +34.0% from the comparable as-filed period.
Shares outstanding changed -87.3% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Operating margin changed +50606 basis points from the comparable as-filed period.
Capital expenditure changed -97.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed -33.8% from the comparable as-filed period.
Cash & equivalents changed +21.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capex / revenue changed -1843 basis points from the comparable as-filed period.
Current liabilities changed +46.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Trade receivables changed +46.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed -57.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +18.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow changed +17.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -13997 basis points from the comparable as-filed period.
Cash / debt changed +583 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Debt / revenue changed +9963 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.